195 related articles for article (PubMed ID: 31158853)
1. Evaluation of Differences in Individual Treatment Response in Schizophrenia Spectrum Disorders: A Meta-analysis.
Winkelbeiner S; Leucht S; Kane JM; Homan P
JAMA Psychiatry; 2019 Oct; 76(10):1063-1073. PubMed ID: 31158853
[TBL] [Abstract][Full Text] [Related]
2. Atypical antipsychotics for psychosis in adolescents.
Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
Cochrane Database Syst Rev; 2013 Oct; (10):CD009582. PubMed ID: 24129841
[TBL] [Abstract][Full Text] [Related]
3. Efficacy, Acceptability, and Tolerability of Antipsychotics in Treatment-Resistant Schizophrenia: A Network Meta-analysis.
Samara MT; Dold M; Gianatsi M; Nikolakopoulou A; Helfer B; Salanti G; Leucht S
JAMA Psychiatry; 2016 Mar; 73(3):199-210. PubMed ID: 26842482
[TBL] [Abstract][Full Text] [Related]
4. Pimozide for schizophrenia or related psychoses.
Mothi M; Sampson S
Cochrane Database Syst Rev; 2013 Nov; (11):CD001949. PubMed ID: 24194433
[TBL] [Abstract][Full Text] [Related]
5. Olanzapine for schizophrenia.
Duggan L; Fenton M; Rathbone J; Dardennes R; El-Dosoky A; Indran S
Cochrane Database Syst Rev; 2005 Apr; (2):CD001359. PubMed ID: 15846619
[TBL] [Abstract][Full Text] [Related]
6. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.
Krzystanek M; Krupka-Matuszczyk I
Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416
[TBL] [Abstract][Full Text] [Related]
7. Systematic reviews of the effectiveness of day care for people with severe mental disorders: (1) acute day hospital versus admission; (2) vocational rehabilitation; (3) day hospital versus outpatient care.
Marshall M; Crowther R; Almaraz-Serrano A; Creed F; Sledge W; Kluiter H; Roberts C; Hill E; Wiersma D; Bond GR; Huxley P; Tyrer P
Health Technol Assess; 2001; 5(21):1-75. PubMed ID: 11532238
[TBL] [Abstract][Full Text] [Related]
8. Zuclopenthixol dihydrochloride for schizophrenia.
Bryan EJ; Purcell MA; Kumar A
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD005474. PubMed ID: 29144549
[TBL] [Abstract][Full Text] [Related]
9. Examining Side Effect Variability of Antipsychotic Treatment in Schizophrenia Spectrum Disorders: A Meta-analysis of Variance.
Neumeier MS; Homan S; Vetter S; Seifritz E; Kane JM; Huhn M; Leucht S; Homan P
Schizophr Bull; 2021 Oct; 47(6):1601-1610. PubMed ID: 34374418
[TBL] [Abstract][Full Text] [Related]
10. Quetiapine versus other atypical antipsychotics for schizophrenia.
Asmal L; Flegar SJ; Wang J; Rummel-Kluge C; Komossa K; Leucht S
Cochrane Database Syst Rev; 2013 Nov; (11):CD006625. PubMed ID: 24249315
[TBL] [Abstract][Full Text] [Related]
11. Control group bias in randomized atypical antipsychotic medication trials for schizophrenia.
Woods SW; Gueorguieva RV; Baker CB; Makuch RW
Arch Gen Psychiatry; 2005 Sep; 62(9):961-70. PubMed ID: 16143728
[TBL] [Abstract][Full Text] [Related]
12. Modafinil for people with schizophrenia or related disorders.
Ortiz-Orendain J; Covarrubias-Castillo SA; Vazquez-Alvarez AO; Castiello-de Obeso S; Arias Quiñones GE; Seegers M; Colunga-Lozano LE
Cochrane Database Syst Rev; 2019 Dec; 12(12):CD008661. PubMed ID: 31828767
[TBL] [Abstract][Full Text] [Related]
13. Quetiapine for schizophrenia.
Srisurapanont M; Maneeton B; Maneeton N
Cochrane Database Syst Rev; 2004; 2004(2):CD000967. PubMed ID: 15106155
[TBL] [Abstract][Full Text] [Related]
14. Dropout rates in placebo-controlled and active-control clinical trials of antipsychotic drugs: a meta-analysis.
Kemmler G; Hummer M; Widschwendter C; Fleischhacker WW
Arch Gen Psychiatry; 2005 Dec; 62(12):1305-12. PubMed ID: 16330718
[TBL] [Abstract][Full Text] [Related]
15. Maintenance treatment with antipsychotic drugs for schizophrenia.
Leucht S; Tardy M; Komossa K; Heres S; Kissling W; Davis JM
Cochrane Database Syst Rev; 2012 May; (5):CD008016. PubMed ID: 22592725
[TBL] [Abstract][Full Text] [Related]
16. Placebo response in antipsychotic clinical trials: a meta-analysis.
Rutherford BR; Pott E; Tandler JM; Wall MM; Roose SP; Lieberman JA
JAMA Psychiatry; 2014 Dec; 71(12):1409-21. PubMed ID: 25321611
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological treatment for psychotic depression.
Wijkstra J; Lijmer J; Burger H; Geddes J; Nolen WA
Cochrane Database Syst Rev; 2013 Nov; (11):CD004044. PubMed ID: 24282034
[TBL] [Abstract][Full Text] [Related]
18. Olanzapine for schizophrenia.
Duggan L; Fenton M; Dardennes RM; El-Dosoky A; Indran S
Cochrane Database Syst Rev; 2003; (1):CD001359. PubMed ID: 12535408
[TBL] [Abstract][Full Text] [Related]
19. Carbamazepine for schizophrenia.
Leucht S; Kissling W; McGrath J; White P
Cochrane Database Syst Rev; 2007 Jul; (3):CD001258. PubMed ID: 17636660
[TBL] [Abstract][Full Text] [Related]
20. Outcome reporting bias in randomized-controlled trials investigating antipsychotic drugs.
Lancee M; Lemmens CMC; Kahn RS; Vinkers CH; Luykx JJ
Transl Psychiatry; 2017 Sep; 7(9):e1232. PubMed ID: 28895941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
